Optic Neuropathy and Chronic Cyanide Intoxication: A Review

Beer G.J. Lehre von den Augenkrankheiten, vol II. Vienna, 1817 (cited by Duke-Elder WSD. Textbook of ophthalmology. London, Henry Kimpton, 1940: vol 3, 3009)

Heaton J.M. , McCormick A.J.A. , Freeman A.G. Tobacco amblyopia: A clinical manifestation of Vitamin B₁₂ deficiency. Lancet 1958; ii: 286–90

Traquair H.M. Toxic amblyopia, including retrobulbar neuritis. Trans Ophthal Soc UK 1930; 50: 351–85

Usher C.H. An analysis of the consumption of tobacco and alcohol in cases of tobacco amblyopia. General discussion. Annals of Eugenics (London) 1927; 2: 245–89

Anonymous. Tobacco amblyopia. Br Med J 1959; i: 1582

Schepens C.L. Is tobacco amblyopia a deficiency disease? Trans Ophthal Soc UK 1946; 66: 309–31

Griffith A.H. Toxic amblyopia. Analysis of cases from the cliniques of Dr Little and Glascott. Trans Ophthal Soc UK 1887; 7: 81–90

Rodger F.C. The relationship of thiamine to the visual pathway. Thesis, University of Glasgow, 1951: 208.

Shattuck G.C. Relation of beri-beri to polyneuritis from other causes. Am J Trop Med 1928; 8: 539–43

Minot G.R. Some fundamental clinical aspects of deficiencies. Ann Intern Med 1929; 3: 216–29

Carroll F.D. The etiology and treatment of tobacco-alcohol amblyopia. Trans Am Ophthal Soc 1943; 41: 385–431

Duke-Elder W.S.D. Textbook of ophthalmology. London: Henry Kimpton, 1954: vol 2,6838

Foulds W.S. , Chisholm I.A. , Bronte-Stewart J. , Wilson T.M. Vitamin B₎₂ absorption in tobacco amblyopia. Br J Ophthal 1969; 53: 393–97

Freeman A.G. , Heaton J.M. The aetiology of retrobulbar neuritis in Addisonian pernicious anaemia. Lancet 1961; i: 908–11

Heaton J.M. Chronic cyanide poisoning and optic neuritis. Trans Ophthal Soc UK 1962; 82: 263–9

Wokes F. Tobacco amblyopia. Lancet 1958; ii: 526

Wilson J. , Matthews D.M. Metabolic inter-relationship between cyanide, thiocyanate and vitamin B₁₂ in smokers and non-smokers. Clin Sci 1966; 31: 1–7

Foulds W.S. , Bronte-Stewart J.M. , Chisholm I.A. Serum thiocyanate concentrations in tobacco amblyopia. Nature (Lond) 1968; 218: 586

Björkenheim B. Optic neuropathy caused by vitamin B₁₂ deficiency in carriers of the fish tapeworm, diphyllobothrium latum. Lancet 1966; i: 688–90.

Adams P. , Chalmers T.M. , Foulds W.S. , Withey J.L. Megaloblastic anaemia and vision. Lancet 1967; ii: 229–31

Freeman A.G. Megaloblastic anaemia and vision. Lancet 1967; ii: 422–3

Matthews D.M. , Wilson J. Cobalamins and cyanide metabolism in neurological disease. In: Arnstein H.R.Y. , Wrighton R.J. , eds. The cobalamins: A Glaxo symposium. London: Churchill Livingstone, 1971: 115

Freeman A.G. Food and cyanide. Br Med J 1972; ii: 49

Osuntokun B.O. , Monekosso G.L. , Wilson J. Relationship of a degenerative tropical neuropathy to diet. Report of a field survey. Br Med J 1969; i: 547–50

Osuntokun B.O. , Osuntokun O. Tropical amblyopia. Am J Ophthalmol 1971; 72: 708–16

Cliff J. , Martenson J. , Lundqvist P. , Rosling H. , Surbo B. Association of high cyanide and low sulphur intake in cassava-induced paraparesis. Lancet 1985; ii: 1211–12

Wilson J. , Linnell J.C. , Matthews D.M. Plasma-cobalamins in neuro-ophthalmological diseases. Lancet 1971; i: 777–78

Wilson J. Leber's hereditary optic atrophy: a possible defect of cyanide metabolism. Clin Sci 1965; 29: 505–15

Wilson J. Cyanide in human disease: a review of clinical and laboratory evidence. Fundamental Applied Toxicology 1983; 3: 397–9

Poole C.J.M. , Kind P.R.N. Deficiency of thiosulphate sulphurtransferase (rhodanese) in Leber's hereditary optic neuropathy. Br Med J 1986; 292: 1229–30

Foulds W.S. , Pettigrew A.R. The biochemical basis of the toxic amblyopias. In: Perkins E.S. , Hill D.W. , eds. Scientific foundations of ophthalmology. London: Heinemann, 1977: 50–4

Nikoskelainen E. , Sogg R.L. , Rosenthal A.R. , Friberg T.R. , Dorfman L.J. The early phase in Leber's hereditary optic atrophy. Arch Ophthalmol 1977; 95: 969–78

Foulds W.S. , Freeman A.G. , Phillips C.I. , Wilson J. Cyanacobalamin: a case for withdrawal. Lancet 1970; i: 35

Freeman A.G. , Wilson J. , Foulds W.S. , Phillips C.I. Why has cyanacobalamin not been withdrawn? Lancet 1978; i: 777–8

Linnell J.C. , Matthews D.M. , England J.M. Therapeutic misuse of cyanocobalamin. Lancet 1978; ii: 1053–4

Terry S.I. , Nicholson G.D. Survival of cyanocobalamin. Lancet 1978; ii: 848

Committee on Safety of Medicines. Current Problems, July 1981: 6

Monthly Index of Medical Specialities. Nov 1986: 175

Freeman A.G. Chronic cyanide intoxication. Br Med J 1981; 282: 1321

Freeman A.G. Thiocyanate metabolism in human vitamin B12 deficiency. Br Med J 1973; i: 231–2